Back to search

Czechia· CZ-0276851

MOXONIDIN VIATRIS

A moxonidine product, registered in Czechia by Mylan Ireland Limited, Dublin. The same ATC class is registered in 13 of our 19 countries.

ATC C02AC05

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedMOXONIDIN VIATRISATCC02AC05REGISTER NO.CZ-0276851PACKS LISTED0CHECKEDJuly 27, 2026

Where it is registered

Moxonidine is registered in 13 of 19 countries.

Countries holding a registration under ATC C02AC05 (moxonidine), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 8 of them publish a price we can compare per daily dose

Moxonidine · ATC C02AC05

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of moxonidine costs, country by country.

Normalised to the WHO defined daily dose (0.3 mg), the median price runs from $0.19 in France to $0.70 in Switzerland — a ×3.7 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Moxonidine · price per daily dose (0.3 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.70
  • IT Italy$0.35
  • FR France$0.19
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

SÚKL (Czech Republic)
Manufacturer
Mylan Ireland Limited, Dublin
Country
Czechia (CZ)
ATC code
C02AC05
ATC class
Moxonidine
Defined daily dose
0.3 mg, O
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
July 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b30233be-feb0-44ff-bf8f-d8c4d3825def
GET /v1/drugs/b30233be-feb0-44ff-bf8f-d8c4d3825def?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL FLM",
  "source": "sukl",
  "strength": "0,4MG",
  "pack_size": "100",
  "substance": "9054",
  "cz_kod_sukl": "0276851",
  "product_type": "CH",
  "registration_state": "B",
  "registration_number": "58/026/10-C"
}

See everything about moxonidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.